QR-koda

TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1

Viruses are able to efficiently penetrate cells, multiply, and eventually kill infected cells, release tumor antigens, and activate the immune system. Therefore, viruses are highly attractive novel agents for cancer therapy. Clinical trials with first generations of oncolytic viruses (OVs) are very...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Christina Funk, Nadja Uhlig, Zsolt Ruzsics, Florentin Baur, Matthias Peindl, Sarah Nietzer, Karina Epting, Gabriele Vacun, Gudrun Dandekar, Catherine Botteron, Christian Werno, Thomas Grunwald, Susanne M. Bailer
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Elsevier 2024-03-01
Ráidu:Molecular Therapy: Oncology
Fáttát:
MT: Regular Issue
oncolytic virotherapy
combined virus immunotherapy
tumor therapy
NSCLC
virus engineering
Liŋkkat:http://www.sciencedirect.com/science/article/pii/S2950329924000262
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid